A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients.
Phase of Trial: Phase IV
Latest Information Update: 27 Apr 2012
At a glance
- Drugs Octreotide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Novartis
- 10 Jun 2017 Biomarkers information updated
- 27 Apr 2012 Location (USA) added as reported by ClinicalTrials.gov.
- 27 Apr 2012 Actual end date (Oct 2005 ) added as reported by ClinicalTrials.gov.